tiprankstipranks
Trending News
More News >
Iofina PLC (GB:IOF)
LSE:IOF
Advertisement

Iofina plc (IOF) AI Stock Analysis

Compare
15 Followers

Top Page

GB:IOF

Iofina plc

(LSE:IOF)

Select Model
Select Model
Select Model
Neutral 70 (OpenAI - 4o)
Rating:70Neutral
Price Target:
27.00p
▲(10.20% Upside)
Iofina plc's overall stock score reflects a stable financial position with strong cash flow generation, balanced by challenges in profitability and operational efficiency. The technical indicators suggest a neutral trend with slightly bullish momentum, while the valuation indicates the stock is reasonably priced. The absence of earnings call data and corporate events limits additional insights.

Iofina plc (IOF) vs. iShares MSCI United Kingdom ETF (EWC)

Iofina plc Business Overview & Revenue Model

Company DescriptionIofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. It offers halogen chemicals, disinfectants, electronic specialty gases, sanitizers, heat stabilizers, preservatives, and specialty intermediates, as well as animal health, mineral separation, and odor control products for use in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, and nylon markets. The company also provides turnkey mid-stream fee based solutions to third party brine stream operators to extract iodine. Iofina plc was founded in 2005 and is based in London, the United Kingdom.
How the Company Makes MoneyIofina generates revenue primarily through the sale of high-purity iodine and iodine derivatives, which are sold to various sectors including pharmaceuticals, agricultural chemicals, and industrial applications. The company employs a unique extraction technology that allows it to efficiently recover iodine from brine, enabling a competitive cost structure. Key revenue streams include direct sales to manufacturers and distributors in these sectors. Additionally, Iofina may engage in strategic partnerships or contracts with companies that require consistent iodine supply, further solidifying its market position and ensuring stable cash flows. Fluctuations in iodine pricing and demand dynamics in end-use markets also significantly influence the company’s earnings.

Iofina plc Financial Statement Overview

Summary
Iofina plc demonstrates a stable financial position with low leverage and strong cash flow generation. However, declining profitability margins and return on equity indicate challenges in maintaining growth and efficiency.
Income Statement
65
Positive
Iofina plc has shown a moderate revenue growth rate of 5.32% in the latest year, with a declining trend in gross profit margin from 31.29% to 24.30%. The net profit margin also decreased from 13.12% to 5.36%, indicating pressure on profitability. The EBIT and EBITDA margins have similarly declined, reflecting challenges in maintaining operational efficiency.
Balance Sheet
75
Positive
The company has a strong balance sheet with a low debt-to-equity ratio of 0.09, indicating low leverage and financial stability. However, the return on equity has decreased from 14.67% to 6.11%, suggesting reduced profitability on shareholder investments. The equity ratio remains robust, highlighting a solid capital structure.
Cash Flow
70
Positive
Iofina plc's free cash flow growth rate has significantly improved by 72.67%, showing enhanced cash generation capabilities. The operating cash flow to net income ratio is healthy at 0.93, indicating efficient cash conversion. However, the free cash flow to net income ratio has decreased, reflecting potential challenges in translating earnings into free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue57.65M54.47M50.04M42.20M39.04M29.69M
Gross Profit14.36M13.24M15.65M15.83M10.73M8.40M
EBITDA8.37M7.65M10.64M11.36M6.85M4.61M
Net Income4.82M2.92M6.56M7.87M9.19M1.28M
Balance Sheet
Total Assets70.23M63.78M60.52M52.71M44.45M39.83M
Cash, Cash Equivalents and Short-Term Investments6.42M6.86M6.52M5.93M5.26M4.38M
Total Debt7.47M4.26M5.84M7.20M8.68M12.62M
Total Liabilities19.91M15.99M15.77M14.73M14.48M19.18M
Stockholders Equity50.32M47.79M44.75M37.97M29.96M20.66M
Cash Flow
Free Cash Flow-1.70M2.02M2.34M2.46M6.41M1.33M
Operating Cash Flow8.37M11.53M8.57M5.55M7.89M3.78M
Investing Cash Flow-9.94M-9.34M-6.10M-3.07M-1.47M-2.43M
Financing Cash Flow2.19M-1.85M-1.88M-1.81M-4.64M-6.58M

Iofina plc Technical Analysis

Technical Analysis Sentiment
Positive
Last Price24.50
Price Trends
50DMA
24.24
Positive
100DMA
24.61
Negative
200DMA
23.11
Positive
Market Momentum
MACD
-0.07
Negative
RSI
59.99
Neutral
STOCH
58.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IOF, the sentiment is Positive. The current price of 24.5 is above the 20-day moving average (MA) of 23.16, above the 50-day MA of 24.24, and above the 200-day MA of 23.11, indicating a bullish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 59.99 is Neutral, neither overbought nor oversold. The STOCH value of 58.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:IOF.

Iofina plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Neutral
£47.48M12.7610.25%8.48%29.33%
66
Neutral
£199.05M283.330.60%1.86%15.56%-92.94%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
£29.61M-92.35%-27.64%35.09%
50
Neutral
£14.16M-12.88%25.56%35.12%
49
Neutral
£9.01M-78.76%-24.85%40.28%
46
Neutral
£5.81M-11.10%14.51%77.27%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IOF
Iofina plc
24.50
5.50
28.95%
GB:DCTA
Directa Plus
8.50
-3.25
-27.66%
GB:HDD
Hardide
7.50
2.12
39.41%
GB:HAYD
Haydale Graphene
0.65
0.39
150.00%
GB:ITX
Itaconix
105.00
-32.50
-23.64%
GB:ZTF
Zotefoams
400.00
6.80
1.73%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 17, 2025